A new study from researchers at the University of Michigan Comprehensive Cancer Center identifies a protein in that microenvironment that promotes the spread of breast cancer cells. It’s part of a well-known family of receptors for which promising inhibitors are being developed.
According to the National Heart, Lung and Blood Institute, 23 percent of women will die within one year after having a heart attack, and nearly 46 percent of women become disabled with heart failure.
Women with early-stage breast cancer who had an intermediate risk recurrence score (RS) from a 21-gene expression assay had similar outcomes, regardless of whether they received chemotherapy, a new study from The University of Texas MD Anderson Cancer finds.
A new investigational delivery method for localized vaginal estrogen therapy that utilizes an applicator free softgel to alleviate moderate-to-severe vaginal pain during intercourse (dyspareunia), a symptom of vulvar and vaginal atrophy (VVA), received high rates of patient satisfaction among post-menopausal women, according to post-trial survey results published in the journal Menopause.
“These survey results show that something as simple as a change to a more elegant delivery system that is easier to use and not messy might empower more post-menopausal women to seek prescription treatment for VVA, and perhaps help them stay with the application guidelines for longer,” said study first author Sheryl Kingsberg, PhD, Division Chief, OB/GYN Behavioral Medicine, UH Cleveland Medical Center.
A team of 18 University of California San Diego School of Medicine and Moores Cancer Center researchers has developed a new tool to analyze an often overlooked aspect of cancer genetics — an alteration that results in the loss or gain in a copy of a gene. This change, known as somatic copy-number alterations, may be key to disease progression and might offer new therapeutic approaches for ovarian cancer and other malignancies.
Researchers have witnessed - for the first time - cancer cells being targeted and destroyed from the inside, by an organo-metal compound discovered by the University of Warwick.
Women have claimed for years that their bodies react differently whether they’re pregnant with a boy or girl. Now evidence, published by Ohio State University researchers shows the sex of a baby is associated with pregnant women’s immune responses.
To celebrate Valentine’s Day, The University of New Mexico Lobo Men’s and Women’s basketball teams are joining forces to honor all those who have beaten breast cancer, still face it, or have lost to it. They plan to hold their Lobos Love Pink basketball games during the same week to raise awareness for breast cancer.
“Every cancer diagnosis should come with a referral to genetic counseling,” says cancer expert Dr. Antonio Giordano, President of the Sbarro Health Research Organization at Temple University.
Researchers from Mayo Clinic have quantified the numbers of various types of immune cells associated with the risk of developing breast cancer. The findings are published in a study in Clinical Cancer Research.
Genetic variations may be one of the important factors that influence breast cancer survivors' responses to the inflammatory processes and vulnerability to lymphedema.
Michigan State University researchers are the first to uncover reasons why a specific type of immune cell acts very differently in females compared to males while under stress, resulting in women being more susceptible to certain diseases.
Breast cancer patients with dense breast tissue have almost a two-fold increased risk of developing disease in the contralateral breast, according to new research from The University of Texas MD Anderson Cancer.
New recommendations for health care providers, published in the American Heart Association journal Circulation, offer a road map to helping women with congenital heart disease have successful pregnancies.
For women who marry later in life, a few extra pounds may accompany their nuptials, a new study led by the University of Arizona suggests. On the other hand, older women who go through a divorce or separation may lose weight and see some positive changes in their health, according to the research.
A new grant from the Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation will allow Monell scientists and collaborators to confirm initial findings of a unique odor pattern for ovarian cancer. The multi-disciplinary team will use the information to customize a portable screening device that can diagnose the deadly disease at early, treatable stages.
A nationwide cancer registry of almost one million patients treated for hormone-sensitive breast cancer shows that one out of six women who should have received post-surgical treatment known as adjuvant endocrine therapy did not get this recommended component of care, which can reduce the odds of recurrence.
Results of a multicenter study of 129 women with advanced breast cancer show that a blood test that spots cancer-linked DNA correctly predicted that most of those patients with higher levels of the tumor markers died significantly earlier than those with lower levels.
Every minute, a woman dies from heart disease in the United States – it is the number one killer of women, causing one in three deaths each year, according to the American Heart Association (AHA).
Georgetown Lombardi Comprehensive Cancer Center researchers have used animal models to reveal new information about the impact – positive and negative – that soy consumption could have on a common breast cancer treatment.
The American Urological Association has given Robert C. Flanigan, MD, chair of Loyola Medicine’s department of urology, the association’s highest honor.
Depending on the specific type, bacteria in a woman’s vagina and cervix may increase the risk of premature birth or protect against it, according to new research from the Perelman School of Medicine at the University of Pennsylvania. Results of the study provide groundbreaking information that the authors suggest could help physicians learn how to prevent preterm birth, either by eliminating the “bad” bacteria, or increasing the “protective” bacteria.
Jepsen is the lead author on a new study, published in the Journal of Bone and Mineral Research, that examined the bone traits of 198 midlife women transitioning through menopause for 14 years. The goal: identifying women who will experience bone fragility well in advance of fracture.
A new study led by clinician-researchers at Beth Israel Deaconess Medical Center (BIDMC) has found that hospital-led interventions over a seven-year period were associated with a significant reduction in the hospital’s Cesarean delivery rate. During the intervention period, researchers found that the Cesarean rate for low-risk women having their first delivery decreased from 34.8 percent to 21.2 percent. The hospital’s overall Cesarean rate also declined from 40 percent to 29.1 percent over the same period.
Anti-inflammatory diets – which tend to be high in vegetables, fruits, fish and whole grains – could boost bone health and prevent fractures in some women, a new study suggests. Researchers examined data from the landmark Women’s Health Initiative to compare levels of inflammatory elements in the diet to bone mineral density and fractures and found new associations between food and bone health.
Women who used a smartphone app as part of a Perioperative Surgical Home (PSH) program were released from the hospital sooner after delivering their babies via cesarean section, according to a study presented at the American Society of Anesthesiologists PRACTICE MANAGEMENT 2017 meeting.
TwoRush University Medical Center executives have been selected to the inaugural class of the Carol Emmott Fellowship, which aims to bridge the disparities in leadership by women throughout the health care field.
Once breast cancer spreads through the body, it can degrade a patient’s healthy bones, causing numerous problems. Scientists at Huntsman Cancer Institute (HCI) at the University of Utah have identified a new way that bones get destroyed through cancer. And they’ve also learned how to block that destruction with a new drug. Initial tests with patients show promising results.
An analysis of 105 female college students showed that those with the highest levels of stored iron and the highest fitness levels had better grades than less-fit women with lower iron stores.
Triple-negative breast cancers, which comprise 15 to 20 percent of all breast tumors, are a particularly deadly type of breast disease that often metastasize to distant sites. Now, University of Missouri researchers have found that luteolin, a natural compound found in herbs such as thyme and parsley, and vegetables such as celery and broccoli, could reduce the risk of developing metastasis originating from triple-negative breast cancer in women.
COLUMBUS, Ohio – The time of day that breast cancer chemotherapy drugs are given affects the amount of damaging inflammation in the body, a new study in mice suggests.
Nearly half of women treated for early stage breast cancer reported at least one side effect from their treatment that was severe or very severe, a new study finds.
Australian researchers are one step closer to breast cancer prevention after finding a new driver for breast density, an identified risk factor for breast cancer.
A woman’s risk of dying of cervical cancer is higher than long believed, particularly among older and black women, new Johns Hopkins Bloomberg School of Public Health-led research suggests.
The Independent Citizens Oversight Committee of the California Institute for Regenerative Medicine (CIRM) has approved a pair of $2 million awards to University of California San Diego School of Medicine researchers to advance studies of new treatments for Zika virus infections and the use of stem cell-derived natural killer (NK) cells to target ovarian cancer and other malignancies.
In the journal Cancer Discovery, UNC Lineberger Comprehensive Cancer Center researchers and colleagues report findings of how triple negative breast cancer cells are able to bypass treatment with trametinib, a U.S. Food and Drug Administration-approved drug that belongs to a class of commonly used anti-cancer drugs called kinase inhibitors. The researchers also reported findings from laboratory models of breast cancer testing a potential treatment approach that could prevent the onset of resistance.
Northwestern Medicine will host a symposium Jan. 25 to celebrate the one-year anniversary of the implementation of the National Institutes of Health’s landmark sex-inclusion policy. The NIH is revolutionizing the future of medicine by mandating that research funding is contingent upon the inclusion of female cells or animals in scientists’ studies.
In this month’s release, find new embargoed research about: impact of minimum wage on teen birth rates; trends in parental leave rates over 22-year period; and food insecurity and cardiovascular-related health outcomes among American Indians.
The number of U.S. women taking maternity leave has not changed in 22 years despite factors that suggest it should be increasing, a new study found. During the same time, the number of fathers taking paternity leave more than tripled.
Administering chemotherapy to African-American breast cancer patients prior to surgery could improve their prognosis and survival rates from the disease, according to a new study.
Genetic counselors are playing a greater role in areas of medicine in the wake of advancement in genomic technology. In the last decade, genetic testing has improved dramatically, enabling medical professionals the ability to screen for common genetic conditions like Down syndrome more accurately beginning at 10 weeks gestation.
Researchers at University of California San Diego School of Medicine report that elderly women who sit for more than 10 hours a day with low physical activity have cells that are biologically older by eight years compared to women who are less sedentary.